These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15990354)

  • 1. Genomics: success or failure to deliver drug targets?
    Betz UA; Farquhar R; Ziegelbauer K
    Curr Opin Chem Biol; 2005 Aug; 9(4):387-91. PubMed ID: 15990354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The information revolution reaches pharmaceuticals: balancing innovation incentives, cost, and access in the post-genomics era.
    Rai AK
    Univ Ill Law Rev; 2001; 2001(1):173-210. PubMed ID: 16493845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural genomics in the biotechnology sector.
    Dry S; McCarthy S; Harris T
    Nat Struct Biol; 2000 Nov; 7 Suppl():946-9. PubMed ID: 11103995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomics. After the gold rush: gene firms reinvent themselves.
    Gura T
    Science; 2002 Sep; 297(5589):1982-4. PubMed ID: 12242421
    [No Abstract]   [Full Text] [Related]  

  • 6. Differentiating genomics companies.
    James R
    Nat Biotechnol; 2000 Feb; 18(2):153-5. PubMed ID: 10657119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The power of genomics to transform the biotechnology industry.
    Haseltine WA
    Nat Biotechnol; 1998 May; 16 Suppl():25-7. PubMed ID: 9591259
    [No Abstract]   [Full Text] [Related]  

  • 8. When will the genomics investment pay off for antibacterial discovery?
    Mills SD
    Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of genomics in clinical trial design.
    Simon R
    Clin Cancer Res; 2008 Oct; 14(19):5984-93. PubMed ID: 18829477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. siRNAs in drug discovery: target validation and beyond.
    Natt F
    Curr Opin Mol Ther; 2007 Jun; 9(3):242-7. PubMed ID: 17608022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics, target discovery and the pharmaceutical/biotechnology industry.
    Fagan R; Swindells M
    Curr Opin Mol Ther; 2000 Dec; 2(6):655-61. PubMed ID: 11249743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How many genomics targets can a portfolio afford?
    Betz UA
    Drug Discov Today; 2005 Aug; 10(15):1057-63. PubMed ID: 16055022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomics, systems biology and drug development for infectious diseases.
    Sakata T; Winzeler EA
    Mol Biosyst; 2007 Dec; 3(12):841-8. PubMed ID: 18000561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction between intellectual property and drug regulatory systems: global perspectives.
    Madden EA
    IDrugs; 2007 Feb; 10(2):116-20. PubMed ID: 17285464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic filtering: an approach to discovering novel antiparasitics.
    McCarter JP
    Trends Parasitol; 2004 Oct; 20(10):462-8. PubMed ID: 15363439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A decade of fragment-based drug design: strategic advances and lessons learned.
    Hajduk PJ; Greer J
    Nat Rev Drug Discov; 2007 Mar; 6(3):211-9. PubMed ID: 17290284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomics in drug discovery: the best things come to those who wait.
    Bansal AT; Barnes MR
    Curr Opin Drug Discov Devel; 2008 May; 11(3):303-11. PubMed ID: 18428083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico identification of putative drug targets from different metabolic pathways of Aeromonas hydrophila.
    Sharma V; Gupta P; Dixit A
    In Silico Biol; 2008; 8(3-4):331-8. PubMed ID: 19032165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural genomics and drug discovery: all in the family.
    Weigelt J; McBroom-Cerajewski LD; Schapira M; Zhao Y; Arrowsmith CH
    Curr Opin Chem Biol; 2008 Feb; 12(1):32-9. PubMed ID: 18282486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in knowledge management for pharmaceutical research and development.
    Torr-Brown S
    Curr Opin Drug Discov Devel; 2005 May; 8(3):316-22. PubMed ID: 15892246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.